Healthlynked Corp (HLYK) — SEC Filings
Healthlynked Corp (HLYK) — 18 SEC filings. Latest: 8-K (Dec 12, 2025). Includes 10 8-K, 6 10-Q, 2 10-K.
View Healthlynked Corp on SEC EDGAR
Overview
Healthlynked Corp (HLYK) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 12, 2025: HealthLynked Corp. filed an 8-K on December 12, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits. The repo
Sentiment Summary
Across 18 filings, the sentiment breakdown is: 3 bearish, 15 neutral. The dominant filing sentiment for Healthlynked Corp is neutral.
Filing Type Overview
Healthlynked Corp (HLYK) has filed 10 8-K, 6 10-Q, 2 10-K with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (18)
Risk Profile
Risk Assessment: Of HLYK's 17 recent filings, 2 were flagged as high-risk, 7 as medium-risk, and 8 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $388,545 |
| Net Income | -$851,800 |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $10,911 |
| Operating Margin | N/A |
| Total Assets | $1,764,557 |
| Total Debt | $7,197,972 |
Key Executives
- Dr. Michael J. Riff
- Ms. Jennifer L. Johnson
Industry Context
The healthcare technology sector is highly competitive, with companies vying for market share through innovation and efficient service delivery. Trends include increasing adoption of digital health platforms, telehealth services, and data analytics for patient care improvement. However, regulatory hurdles, data privacy concerns, and the need for significant capital investment are persistent challenges.
Top Tags
corporate-governance (4) · 10-Q (4) · healthcare (4) · quarterly-report (3) · financial-obligation (3) · Healthcare Technology (2) · Net Loss (2) · Liquidity Risk (2) · Revenue Decline (2) · material-agreement (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Cash at September 30, 2025 | $10,911 | Represents a significant decrease from $76,241 at December 31, 2024, indicating severe liquidity issues. |
| Net loss for Q3 2025 | $851,800 | Improved from $1,973,119 in Q3 2024, but still a substantial loss. |
| Net loss for the nine months ended September 30, 2025 | $2,603,777 | Improved from $4,901,273 in the prior year, but still a significant deficit. |
| Total revenue for Q3 2025 | $388,545 | Decreased from $590,124 in Q3 2024, indicating declining sales. |
| Total revenue for the nine months ended September 30, 2025 | $1,755,113 | Decreased from $2,389,434 in the prior year, showing a consistent revenue decline. |
| Total Liabilities at September 30, 2025 | $7,197,972 | Increased from $5,352,198 at December 31, 2024, driven by related party debt. |
| Notes payable to related party at September 30, 2025 | $5,216,072 | Increased significantly from $3,212,521 at December 31, 2024, indicating reliance on related party financing. |
| Reverse Stock Split Ratio | 1-for-100 | Effected on September 4, 2025, reducing outstanding shares from 284,750,832 to 2,847,873. |
| SEC File Number | 000-55768 | Identifies the company's filing with the SEC. |
| IRS Employer Identification No. | 47-1634127 | Company's tax identification number. |
| Total Revenue | $1,366,568 | Decreased by 24.05% for the six months ended June 30, 2025, from $1,799,310 in 2024. |
| Net Loss | $(1,751,977) | Widened for the six months ended June 30, 2025, from $(2,928,154) in 2024, representing a 40.10% improvement in net loss. |
| Cash | $20,201 | Decreased significantly from $76,241 at December 31, 2024, indicating severe liquidity issues. |
| Total Liabilities | $6,600,768 | Increased from $5,352,198 at December 31, 2024, significantly exceeding total assets. |
| Total Shareholders' Deficit | $(4,752,318) | Deepened from $(3,129,209) at December 31, 2024, reflecting ongoing losses. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Healthlynked Corp (HLYK)?
Healthlynked Corp has 18 recent SEC filings from Jan 2024 to Dec 2025, including 10 8-K, 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of HLYK filings?
Across 18 filings, the sentiment breakdown is: 3 bearish, 15 neutral. The dominant sentiment is neutral.
Where can I find Healthlynked Corp SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Healthlynked Corp (HLYK) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Healthlynked Corp?
Key financial highlights from Healthlynked Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for HLYK?
The investment thesis for HLYK includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Healthlynked Corp?
Key executives identified across Healthlynked Corp's filings include Dr. Michael J. Riff, Ms. Jennifer L. Johnson.
What are the main risk factors for Healthlynked Corp stock?
Of HLYK's 17 assessed filings, 2 were flagged high-risk, 7 medium-risk, and 8 low-risk.
What are recent predictions and forward guidance from Healthlynked Corp?
Forward guidance and predictions for Healthlynked Corp are extracted from SEC filings as they are enriched.